SL
DSGN icon

Siren LLC’s Design Therapeutics DSGN Stock Holding History

Siren LLC’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.57M Buy
+523,212
New +$6.52M 0.15% 79

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Siren LLC's DSGN Position: Q2 2026 in Review

Siren LLC opened a new position in Design Therapeutics (DSGN) in Q2 2026: 523,212 shares worth $7.57M. The stake represents 0.15% of the portfolio and ranks #79 among its holdings.

84 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Siren LLC held 523,212 shares of Design Therapeutics worth $7.57M as of Q2 2026.
  • Design Therapeutics was a new Siren LLC position in Q2 2026.
  • Design Therapeutics made up 0.15% of Siren LLC's portfolio in Q2 2026, its #79 holding.
  • 84 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.